Research ArticleResearch

Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping

Mingyan Cao, Wenjun (David) Mo, Anthony Shannon, Ziping Wei, Michael Washabaugh and Patricia Cash
PDA Journal of Pharmaceutical Science and Technology November 2016, 70 (6) 490-507; DOI: https://doi.org/10.5731/pdajpst.2015.006239

Article Information

vol. 70 no. 6 490-507
DOI 
https://doi.org/10.5731/pdajpst.2015.006239
PubMed 
27091886
Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online December 13, 2016.

Article Versions

Copyright & Usage 
© PDA, Inc. 2016

Author Information

  1. Mingyan Cao,
  2. Wenjun (David) Mo,
  3. Anthony Shannon,
  4. Ziping Wei,
  5. Michael Washabaugh* and
  6. Patricia Cash*
  1. Analytical Biotechnology Department, MedImmune Inc, Gaithersburg, MD
  1. ↵* Corresponding Authors: Michael Washabaugh, Current affiliation: TheraProteins Inc., 3440 S. Dearborn St. Suite 300, Chicago, IL 60616; e-mail: michael.washabaugh{at}theraproteins.com; Patricia Cash; e-mail: Patriciacash8{at}gmail.com

  • Current affiliation of Wenjun (David) Mo: Bio-Thera Solutions, Ltd, Guangzhou, China; Current affiliation of Ziping Wei: Novavax Inc, 9920 Belward Campus Drive, Rockville, MD 20850.

View Full Text

Cited By...

Back to top

In This Issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping
Mingyan Cao, Wenjun (David) Mo, Anthony Shannon, Ziping Wei, Michael Washabaugh, Patricia Cash
PDA Journal of Pharmaceutical Science and Technology Nov 2016, 70 (6) 490-507; DOI: 10.5731/pdajpst.2015.006239
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords